Novartis' Maalox Labels Linked With Serious Errors

Law360, New York (February 18, 2010, 5:03 PM EST) -- Novartis Consumer Health Inc.'s over-the-counter anti-diarrhea medication Maalox Total Relief has been involved in several serious mix-ups with Maalox antacids and will be relabeled, the U.S. Food and Drug Administration said.

The drug has been linked with five “serious medication errors” where customers used Total Relief when they intended to use a traditional Maalox liquid antacid, the FDA said Wednesday in a statement.

Novartis has agreed to rebrand Total Relief with a name that will not include “Maalox” and change the packaging to help distinguish the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.